Table 1. Patient Demographics and Clinical Characteristics before the Ultrasound-Guided Thrombin Injection.
| Characteristics | Value | |||
|---|---|---|---|---|
| Number of patients | 30 | |||
| Age | 67.8 ± 13.9 (38–88) | |||
| Sex | ||||
| Male | 19 (63.3) | |||
| Female | 11 (36.6) | |||
| Procedure | ||||
| Peripheral angiography and intervention | 15 (50) | |||
| Cardiac catheterization | 8 (26.6) | |||
| CRRT catheterization | 2 (6.7) | |||
| Other transarterial embolization | 5 (16.7) | |||
| BMI (kg/m2) | ||||
| < 25 | 26 (86.7) | |||
| > 25 | 4 (13.3) | |||
| Symptom | ||||
| None | 5 (16.6) | |||
| Inguinal swelling | 21 (70) | |||
| Ecchymosis | 16 (53.3) | |||
| Pain | 7 (23.3) | |||
| Palpable mass | 3 (10) | |||
| Coagulation profile | ||||
| Platelet (K/µL) | 206.38 ± 95.32 (64–439) | |||
| PT (INR) | 1.34 ± 0.37 (0.98–2.51) | |||
| aPTT (second) | 50.82 ± 19.68 (25.7–112.2) | |||
| Antithrombotic medication | ||||
| None | 13 (43.3) | |||
| On medication | 17 (56.7) | |||
| Sac size (mm) | ||||
| Greatest diameter | 20.88 ± 10.02 (5–40) | |||
| Neck width | 2.50 ± 1.24 (1–6) | |||
| Complexity | ||||
| Uniloculated | 14 (46.6) | |||
| Multiloculated | 16 (53.3) | |||
| Site of pseudoaneurysm | ||||
| Common femoral artery | 18 (60) | |||
| Superficial femoral artery | 12 (40) | |||
| Right | 21 (70) | |||
| Left | 9 (30) | |||
| Interval between procedure and treatment (days) | 10.16 ± 9.23 (0–35) | |||
| Thrombin dose (IU) | 437.62 (100–1300) | |||
Data are mean ± standard deviation or n (%) values.
aPTT = activated partial thromboplastin time, BMI = body mass index, CRRT = continuous renal replacement therapy, INR = international normalized ratio, PT = prothrombin time